2018
DOI: 10.1111/idh.12372
|View full text |Cite
|
Sign up to set email alerts
|

A 5‐week randomized clinical evaluation of a novel electric toothbrush head with regular and tapered bristles versus a manual toothbrush for reduction of gingivitis and plaque

Abstract: Objective To evaluate the efficacy of an oscillating‐rotating (O‐R) electric rechargeable toothbrush with a novel round brush head comprised of regular and tapered bristles in reducing plaque and gingivitis versus a manual toothbrush. Methods This was a randomized, examiner‐blind, parallel group, five‐week study. Participants with mild‐to‐moderate plaque and gingivitis received an oral examination and were evaluated for baseline plaque (Rustogi Modified Navy Index), gingivitis (Modified Gingival Index) and gin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
20
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8

Relationship

5
3

Authors

Journals

citations
Cited by 18 publications
(21 citation statements)
references
References 17 publications
(39 reference statements)
0
20
0
Order By: Relevance
“…At the baseline visit, subjects gave informed consent, followed by a review of their medical history, demographic information, and study inclusion/exclusion criteria. Subjects received a pre‐brushing oral examination followed by MGI and GBI evaluations by an experienced examiner 10,14,25,26 . Next, plaque was disclosed using Chrom‐O‐Red erythrosine FD&C red 3 disclosing solution (Germiphene Corp., Bradford, Ontario, Canada) according to the manufacturer’s instructions.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…At the baseline visit, subjects gave informed consent, followed by a review of their medical history, demographic information, and study inclusion/exclusion criteria. Subjects received a pre‐brushing oral examination followed by MGI and GBI evaluations by an experienced examiner 10,14,25,26 . Next, plaque was disclosed using Chrom‐O‐Red erythrosine FD&C red 3 disclosing solution (Germiphene Corp., Bradford, Ontario, Canada) according to the manufacturer’s instructions.…”
Section: Methodsmentioning
confidence: 99%
“…Next, plaque was disclosed using Chrom‐O‐Red erythrosine FD&C red 3 disclosing solution (Germiphene Corp., Bradford, Ontario, Canada) according to the manufacturer’s instructions. The experienced examiner 10,14,25,26 conducted an RMNPI plaque assessment after disclosure.…”
Section: Methodsmentioning
confidence: 99%
“…During the study visit, subjects gave informed consent, followed by a review of their medical history, demographic information, and study inclusion/exclusion criteria. Subjects received a pre‐brushing oral soft tissue assessment and MGI and GBI evaluations by an experienced examiner 12,16,21,22 . After the gingival assessments were completed, plaque was disclosed using Chrom‐O‐Red erythrosine FD&C red 3 disclosing solution (Germiphene Corp., Bradford, Ontario, Canada) according to the manufacturer’s instructions.…”
Section: Methodsmentioning
confidence: 99%
“…After the gingival assessments were completed, plaque was disclosed using Chrom‐O‐Red erythrosine FD&C red 3 disclosing solution (Germiphene Corp., Bradford, Ontario, Canada) according to the manufacturer’s instructions. A RMNPI plaque assessment was conducted by the experienced examiner 12,16,21,22 .…”
Section: Methodsmentioning
confidence: 99%
“…Since its introduction, Oral‐B has continuously innovated the O‐R rechargeable electric toothbrush design to further improve cleaning, compliance, and the brushing experience. Advancements have included increased oscillations, more ergonomic handle designs, improved brush head design and filament technology, timers, pressure sensors, brushing mode selections, and customizable interactive features via ‘Smart’ technology for real‐time feedback and coaching linking a mobile app and the brush to monitor brushing habits 12,14,33‐39 .…”
Section: Introductionmentioning
confidence: 99%